Phibro Animal Health (NASDAQ:PAHC) Cut to “Hold” at StockNews.com

StockNews.com cut shares of Phibro Animal Health (NASDAQ:PAHCFree Report) from a buy rating to a hold rating in a report released on Tuesday.

Several other equities analysts also recently weighed in on PAHC. Morgan Stanley lifted their target price on Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research report on Tuesday, December 17th. Barclays upped their target price on shares of Phibro Animal Health from $20.00 to $22.00 and gave the stock an “underweight” rating in a research note on Monday, February 10th. Two investment analysts have rated the stock with a sell rating and three have given a hold rating to the company’s stock. According to MarketBeat, Phibro Animal Health has a consensus rating of “Hold” and a consensus target price of $21.00.

Check Out Our Latest Research Report on PAHC

Phibro Animal Health Trading Up 0.2 %

NASDAQ PAHC opened at $21.68 on Tuesday. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37. The stock has a market capitalization of $878.11 million, a P/E ratio of 45.17, a PEG ratio of 0.45 and a beta of 0.58. The firm’s 50-day moving average is $22.77 and its two-hundred day moving average is $22.65. Phibro Animal Health has a 12 month low of $12.17 and a 12 month high of $26.55.

Phibro Animal Health (NASDAQ:PAHCGet Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, topping the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. On average, sell-side analysts anticipate that Phibro Animal Health will post 1.95 earnings per share for the current year.

Phibro Animal Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Wednesday, March 5th were paid a dividend of $0.12 per share. The ex-dividend date was Wednesday, March 5th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.21%. Phibro Animal Health’s payout ratio is 100.00%.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Sterling Capital Management LLC increased its position in shares of Phibro Animal Health by 2.4% in the 4th quarter. Sterling Capital Management LLC now owns 18,762 shares of the company’s stock valued at $394,000 after purchasing an additional 448 shares during the last quarter. Rhumbline Advisers increased its holdings in Phibro Animal Health by 0.6% in the fourth quarter. Rhumbline Advisers now owns 76,582 shares of the company’s stock valued at $1,608,000 after buying an additional 484 shares during the last quarter. Los Angeles Capital Management LLC increased its holdings in Phibro Animal Health by 2.1% in the fourth quarter. Los Angeles Capital Management LLC now owns 24,042 shares of the company’s stock valued at $505,000 after buying an additional 503 shares during the last quarter. BNP Paribas Financial Markets lifted its holdings in Phibro Animal Health by 3.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company’s stock worth $548,000 after buying an additional 729 shares during the last quarter. Finally, New York State Teachers Retirement System boosted its position in shares of Phibro Animal Health by 16.7% during the 4th quarter. New York State Teachers Retirement System now owns 5,428 shares of the company’s stock worth $114,000 after acquiring an additional 775 shares in the last quarter. Hedge funds and other institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Company Profile

(Get Free Report)

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

Featured Articles

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.